Catalyst Wire Dossier Catalyst Wire Dossier

TRX103

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TRX103, covering 2026-02-23 to 2026-02-23. Get the full timeline:

Most recent: Clinical Trial Update: A Proof-of-concept Trial to EvaluAte the efficaCy and Safety Of Cell Therapy TRX103 in Patients With Active, Non-infectious Uveitis [Phase 1]

See pricing